These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 25778309)

  • 61. Comparison of EGFR mutation status between plasma and tumor tissue in non-small cell lung cancer using the Scorpion ARMS method and the possible prognostic significance of plasma EGFR mutation status.
    Duan H; Lu J; Lu T; Gao J; Zhang J; Xu Y; Wang M; Wu H; Liang Z; Liu T
    Int J Clin Exp Pathol; 2015; 8(10):13136-45. PubMed ID: 26722512
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Genetic mutation screen in early non--small-cell lung cancer (NSCLC) specimens.
    Bar J; Damianovich M; Hout Siloni G; Dar E; Cohen Y; Perelman M; Ben Nun A; Simansky D; Yellin A; Urban D; Onn A
    Clin Lung Cancer; 2014 Mar; 15(2):159-65. PubMed ID: 24370118
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of EGFR mutation rates in lung adenocarcinoma tissue and pleural effusion samples.
    Guan Y; Wang ZJ; Wang LQ; Hua DF; Liu J
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173189
    [TBL] [Abstract][Full Text] [Related]  

  • 64. EGFR mutation testing using archival-stained smears in non-small cell lung carcinoma.
    Ozluk Y; Firat P; Yegen G; Hocaoglu J; Tas S; Yilmazbayhan D
    Cytopathology; 2017 Feb; 28(1):35-45. PubMed ID: 27389045
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Detection of epidermal growth factor receptor mutations in non-small cell lung cancer by real-time PCR using TaqMan-MGB probes].
    Zhou CC; Zhou SW; Pan H; Su B; Gao ZQ
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):119-23. PubMed ID: 17645848
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [A standard protocol for detection of EGFR mutations in cytologic specimens].
    Wang Z; Wu X; Shi Y; Han X; Cheng G; Li L; Zhang L; Zhang Y; Mu X; Zhu G; Fan Z; Yang L; Di J; Jia X; Liu D
    Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):516-21. PubMed ID: 25327657
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A novel, rapid point-of-care test for lung cancer patients to detect epidermal growth factor receptor gene mutations by using real-time droplet-PCR and fresh liquid cytology specimens.
    Asaka S; Yoshizawa A; Matsuda K; Yamaguchi A; Yamamoto H; Shiina T; Nakata R; Ogawa K; Zhang M; Honda T
    Oncol Rep; 2017 Feb; 37(2):1020-1026. PubMed ID: 27922678
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Profile of the therascreen® EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancer.
    Hsiue EH; Lee JH; Lin CC; Yang JC
    Expert Rev Mol Diagn; 2016 Dec; 16(12):1251-1257. PubMed ID: 27737606
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomes.
    Lozano MD; Zulueta JJ; Echeveste JI; Gúrpide A; Seijo LM; Martín-Algarra S; Del Barrio A; Pio R; Idoate MA; Labiano T; Perez-Gracia JL
    Oncologist; 2011; 16(6):877-85. PubMed ID: 21572125
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cytology smears as diagnostic material for EGFR gene testing in non-small cell lung cancer.
    Powrózek T; Krawczyk P; Pankowski J; Reszka K; Jakubiak M; Obrochta A; Wojas-Krawczyk K; Buczkowski J; Milanowski J
    Tumori; 2015 Nov; 101(6):e151-3. PubMed ID: 26108238
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quantification of plasma EGFR mutations in patients with lung cancers: Comparison of the performance of ARMS-Plus and droplet digital PCR.
    Wang L; Guo Q; Yu W; Qiao L; Zhao M; Zhang C; Hu X; Yang G; Xiong L; Lou J
    Lung Cancer; 2017 Dec; 114():31-37. PubMed ID: 29173762
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas.
    Sharma S; Satapathy A; Aggarwal A; Dewan A; Jain E; Katara R; Kumar V; Pal R; Pandey S; Naidu MM; Kini L; Pradhan D; Mohanty SK
    Pathol Res Pract; 2021 Apr; 220():153394. PubMed ID: 33706124
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficiency of EGFR mutation analysis for small microdissected cytological specimens using multitech DNA extraction solution.
    Oh SY; Lee HT
    Cancer Cytopathol; 2015 Jul; 123(7):401-12. PubMed ID: 25964184
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Droplet digital PCR improved the EGFR mutation diagnosis with pleural fluid samples in non-small-cell lung cancer patients.
    Li X; Liu Y; Shi W; Xu H; Hu H; Dong Z; Zhu G; Sun Y; Liu B; Gao H; Tang C; Liu X
    Clin Chim Acta; 2017 Aug; 471():177-184. PubMed ID: 28602964
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer.
    Yoon SH; Choi YD; Oh IJ; Kim KS; Choi H; Chang J; Shin HJ; Park CK; Kim YC
    Cancer Res Treat; 2015 Oct; 47(4):661-9. PubMed ID: 25715768
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.
    Evrard SM; Taranchon-Clermont E; Rouquette I; Murray S; Dintner S; Nam-Apostolopoulos YC; Bellosillo B; Varela-Rodriguez M; Nadal E; Wiedorn KH; Melchior L; Andrew E; Jones M; Ridgway J; Frykman C; Lind L; Rot M; Kern I; Speel EJM; Roemen GMJM; Trincheri N; Freiberger SN; Rechsteiner M
    J Mol Diagn; 2019 Nov; 21(6):1010-1024. PubMed ID: 31445213
    [TBL] [Abstract][Full Text] [Related]  

  • 77. EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center.
    Giannini R; Lupi C; Sensi E; Alì G; Proietti A; Boldrini L; Servadio A; Giordano M; Macerola E; Bruno R; Borrelli N; Chella A; Melfi F; Lucchi M; Ribechini A; Vasile E; Cappuzzo F; Mussi A; Fontanini G
    Oncol Rep; 2016 Aug; 36(2):1166-72. PubMed ID: 27373829
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preanalytic parameters in epidermal growth factor receptor mutation testing for non-small cell lung carcinoma: A review of cytologic series.
    da Cunha Santos G; Saieg MA
    Cancer Cytopathol; 2015 Nov; 123(11):633-43. PubMed ID: 26288231
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sea-urchin-like Au nanocluster with surface-enhanced raman scattering in detecting epidermal growth factor receptor (EGFR) mutation status of malignant pleural effusion.
    Wang L; Guo T; Lu Q; Yan X; Zhong D; Zhang Z; Ni Y; Han Y; Cui D; Li X; Huang L
    ACS Appl Mater Interfaces; 2015 Jan; 7(1):359-69. PubMed ID: 25495142
    [TBL] [Abstract][Full Text] [Related]  

  • 80. EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.
    Ellison G; Zhu G; Moulis A; Dearden S; Speake G; McCormack R
    J Clin Pathol; 2013 Feb; 66(2):79-89. PubMed ID: 23172555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.